Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

14 November 2017 : Original article

Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients

DOI: 10.12659/AOT.904417

Ann Transplant 2017; 22:677-681

Related articles

28 Jun 2019 : Original article

Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates

Meghan Aversa, Luke Benvenuto [...]

DOI: 10.12659/AOT.915769

Ann Transplant 2019; 24:383-392

1199 22 16

27 Aug 2019 : Original article

A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study

Jérôme Dumortier, Christophe Duvoux [...]

DOI: 10.12659/AOT.916041

Ann Transplant 2019; 24:506-516

1272 14 53

23 Aug 2018 : Original article

Early Sirolimus-Based Immunosuppression is Safe for Lung Transplantation Patients: Retrospective, Single Arm, Exploratory Study

Jacek Wojarski, Sławomir Żegleń [...]

DOI: 10.12659/AOT.908471

Ann Transplant 2018; 23:598-607

1148 12 32

17 Mar 2017 : Original article

Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation

Diego Aguiar, Diego Martínez-Urbistondo [...]

DOI: 10.12659/AOT.901556

Ann Transplant 2017; 22:141-147

1432 67 23

11 Aug 2017 : Original article

Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation

Yutaka Hirano, Seiichiro Sugimoto [...]

DOI: 10.12659/AOT.904225

Ann Transplant 2017; 22:484-492

1461 84 23

14 Mar 2013

Rapidly fatal disseminated acanthamoebiasis in a single lung transplant recipient

Kamyar Afshar, Ayana BoydKing [...]

DOI: 10.12659/AOT.883846

Ann Transplant 2013; 18:107-110

857 22 15

12 May 2014 : Original article

Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats

Ivan Matia, Peter Fellmer [...]

DOI: 10.12659/AOT.889870

Ann Transplant 2014; 19:225-232

1067 16 19

29 Oct 2013

Lung cancer screening with low-radiation dose computed tomography after liver transplantation

Jose Ignacio Herrero, Gorka Bastarrika [...]

DOI: 10.12659/AOT.884021

Ann Transplant 2013; 18:587-592

993 17 14

04 Mar 2013

Incidence of malignancies in cardiac allograft recipients – a single-center experience

Małgorzata Sobieszczańska-Małek, Krzysztof Komuda [...]

DOI: 10.12659/AOT.883843

Ann Transplant 2013; 18:87-93

709 8 11

29 Jun 2012

Tacrolimus-induced nephrotoxicity and genetic variability: A review

Violette M.G.J. Gijsen, Parvaz Madadi [...]

DOI: 10.12659/AOT.883229

Ann Transplant 2012; 17(2): 111-121

1818 99 24

31 Mar 2012

Malignancy after kidney transplantation

Behzad Einollahi,

DOI: 10.12659/AOT.882649

Ann Transplant 2012; 17(1): 145-146

1057 8 14

07 Mar 2017 : Original article

Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1

Zheng Tang, Wei Zhai [...]

DOI: 10.12659/AOT.902002

Ann Transplant 2017; 22:128-137

1002 10 16

15 Aug 2014 : Original article

Volatility of Serum Creatinine Relative to Tacrolimus Levels Predicts Kidney Transplant Rejection

Sarah Schmid, Rhonda Bryce [...]

DOI: 10.12659/AOT.890815

Ann Transplant 2014; 19:403-406

1011 9 23

30 Sep 2011

Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation

Kyota Fukazawa, Seigo Nishida [...]

Ann Transplant 2011; 16(3): 139-142

1521 73 25

30 Jun 2011

Malignancy after renal transplantation in the new era of immunosuppression

Ewa Watorek, Maria Boratynska [...]

Ann Transplant 2011; 16(2): 14-18

929 21 10

23 Mar 2011

Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of Tacrolimus in Chinese renal transplant patients

Ping Wu, Xuefeng Ni [...]

Ann Transplant 2011; 16(1): 54-60

773 17 23

10 Aug 2018 : Original article

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study

Florentine Garaix, Marc Stern [...]

DOI: 10.12659/AOT.908522

Ann Transplant 2018; 23:561-571

1173 34 30

06 Dec 2016 : Original article

De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors

Albino Eccher, Luigino Boschiero [...]

DOI: 10.12659/AOT.900386

Ann Transplant 2016; 21:745-754

1367 21 19

05 Jan 2016 : Original article

Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization

Kyle M. Gardiner, Susan E. Tett [...]

DOI: 10.12659/AOT.895664

Ann Transplant 2016; 21:1-11

1158 16 38

23 Jun 2014 : Original article

Incidence of malignant neoplasia after heart transplantation – a comparison between cyclosporine a and tacrolimus

Uwe Fuchs, Sarah Klein [...]

DOI: 10.12659/AOT.890199

Ann Transplant 2014; 19:300-304

1063 16 31

14 Nov 2014 : Original article

Myeloproliferative Neoplasms and Recurrent Thrombotic Events in Patients Undergoing Liver Transplantation for Budd-Chiari Syndrome: A Single-Center Experience

Urszula Oldakowska-Jedynak, Mateusz Ziarkiewicz [...]

DOI: 10.12659/AOT.890834

Ann Transplant 2014; 19:591-597

1520 27 22

07 Aug 2013

Evolution to twice daily bolus intravenous tacrolimus: Optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant

Gregory I. Snell, Steven Ivulich [...]

DOI: 10.12659/AOT.883993

Ann Transplant 2013; 18:399-407

1494 65 18

31 Dec 2003

Donor Transmitted Malignancies

Joseph Buell, Thomas M. Beebe [...]

Ann Transplant 2004; 9(1): 53-56

852 170 3

01 Aug 2004

Bone marrow transplantation in the course of hematological malignancies – Follow-up study in blood serum by 31P MRS

Małgorzata Kuliszkiewicz-Janus, Stanisław Baczyński [...]

Med Sci Monit 2004; 10(8): CR485-492

879 0 3

21 Oct 2002

Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies.

Alessandro Busca, Benedetto Bruno [...]

Med Sci Monit 2002; 8(10): RA221-232

1115 5 6

In Press

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

15 Mar 2024 : Review article  

Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...

Ann Transplant In Press; DOI: 10.12659/AOT.941185  

18 Mar 2024 : Original article  

Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...

Ann Transplant In Press; DOI: 10.12659/AOT.943282  

20 Mar 2024 : Original article  

Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single Institution

Ann Transplant In Press; DOI: 10.12659/AOT.942252  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358